| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.019 | 0.9 |